In-host population dynamics of Mycobacterium tuberculosis complex during active disease

Roger Vargas, Luca Freschi, Maximillian G. Marin, L. Elaine Epperson, Melissa Smith, Irina Oussenko, David Durbin, Michael Strong, Max Salfinger, Maha FarhateLife 2021 · DOI

TL;DR

This study dives deep into the genetic evolution of Mycobacterium tuberculosis (Mtb) within individual patients during active TB disease. By analyzing longitudinal whole-genome sequencing data from 200 patients, researchers identified key genes under selection, including those related to antibiotic resistance and host immune modulation, and found that low-frequency resistance variants can predict future drug resistance.

What Problem Does This Paper Address?

Tuberculosis (TB) remains a global health crisis, and understanding how the causative agent, Mycobacterium tuberculosis complex (Mtbc), evolves within a host is crucial for developing effective treatments and vaccines. While we know that Mtb populations are not clonal and can exhibit genetic diversity, pinpointing the specific evolutionary pressures and genetic changes occurring during an infection, especially in the context of treatment failure or relapse, has been challenging. Previous studies often lacked longitudinal data or sufficient sample sizes to capture these subtle, in-host dynamics. This paper aims to bridge that gap by providing a detailed, longitudinal view of Mtb's genetic landscape within patients, revealing how the pathogen adapts and potentially develops resistance over time.

Methods

The researchers employed Whole-Genome Sequencing (WGS) on clinical Mtb isolates collected longitudinally from patients. A key methodological contribution is their rigorous filtering process to exclude samples with contamination, mixed infections, or evidence of reinfection, ensuring they were analyzing true in-host evolution of a single Mtb strain. They developed a framework to identify and analyze allele frequency changes in specific genes, particularly those associated with antibiotic resistance. To assess evolutionary pressures, they used phylogenetic convergence analysis on a large global dataset of Mtb isolates. They also developed a simulation pipeline using reference genomes to validate their SNP calling accuracy, especially in challenging repetitive genomic regions.

Datasets

The study utilized longitudinal clinical Mtb isolates from 200 patients with active TB disease. Additionally, they incorporated a large dataset of 20,352 publicly available global Mtb isolates for phylogenetic analysis.

Key Insights and Ideas

  • Low-frequency resistance predicts future fixation: The finding that resistance variants present at just 19% in an early sample can predict their fixation later in the infection is a significant insight for early detection and intervention.
  • Host immunity as a selective pressure: Identifying genes involved in modulating host innate immunity that are under positive selection suggests a dynamic co-evolutionary arms race between Mtb and the human immune system within the host.
  • PE/PPE genes are hotspots for evolution: The observation that PE/PPE genes, often considered less understood, show significant in-host diversity points to their potential role in host adaptation and warrants further investigation.
  • Reinfection is common: The high percentage of mixed infections or reinfections observed highlights the importance of considering these factors in treatment strategies and transmission control.

Key Results

  • Out of 200 patients with persistent clonal infection, 27 developed new resistance mutations.
  • A low-frequency variant (≥19% allele frequency in the first isolate) predicted subsequent fixation of resistance with 95.8% specificity.
  • Significant in-host variation was identified in 27 genes, including antibiotic resistance genes and those involved in host immune modulation.
  • Phylogenetic convergence analysis confirmed that several in-host mutations arose independently in different global lineages, suggesting strong selective pressures.
  • The study found that 28% of samples collected more than two months apart showed evidence of mixed infection or reinfection.

Limitations and Future Work

The authors acknowledge that the sensitivity of their 19% threshold for predicting resistance fixation is low, as many sweeping mutations are undetectable at the first time point. This suggests that more frequent sampling or higher sequencing depth might be needed for earlier detection. They also note that in vitro culturing can introduce experimental noise and potentially purge genetic diversity from sputum samples, suggesting that direct sputum sequencing methods could offer a more unbiased view of in-host evolution. Future work could focus on refining these early detection methods and further exploring the functional roles of the identified adaptive genes, particularly the PE/PPE family, in host-pathogen interactions and vaccine development.

Summary updated

Abstract

Tuberculosis (TB) is a leading cause of death globally. Understanding the population dynamics of TB's causative agent <i>Mycobacterium tuberculosis</i> complex (Mtbc) in-host is vital for understanding the efficacy of antibiotic treatment. We use longitudinally collected clinical Mtbc isolates that underwent Whole-Genome Sequencing from the sputa of 200 patients to investigate Mtbc diversity during the course of active TB disease after excluding 107 cases suspected of reinfection, mixed infection or contamination. Of the 178/200 patients with persistent clonal infection >2 months, 27 developed new resistance mutations between sampling with 20/27 occurring in patients with pre-existing resistance. Low abundance resistance variants at a purity of ≥19% in the first isolate predict fixation in the subsequent sample. We identify significant in-host variation in 27 genes, including antibiotic resistance genes, metabolic genes and genes known to modulate host innate immunity and confirm several to be under positive selection by assessing phylogenetic convergence across a genetically diverse sample of 20,352 isolates.
BibTeX
@inproceedings{vargas2021host,
  author = {Roger Vargas and Luca Freschi and Maximillian G. Marin and L. Elaine Epperson and Melissa Smith and Irina Oussenko and David Durbin and Michael Strong and Max Salfinger and Maha Farhat},
  title = {{In-host population dynamics of Mycobacterium tuberculosis complex during active disease}},
  booktitle = {eLife},
  year = {2021},
  doi = {10.7554/elife.61805},
}
Figure